New diabetes clinical trial: Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule

Published on: February 05, 2025 at 11:00PM
Conditions: Type 1 Diabetes Mellitus
Interventions: Drug: SAR442970; Drug: Placebo
Sponsors: Sanofi
Not yet recruiting
https://ift.tt/cSRj2bU